Announcing the Re-Launch of the Diversity in Innovation Law Firm Toolkit
Presented by IPO's Women in IP Committee
The Intellectual Property Owners Association (IPO) Diverse Inventors subcommittee of the Women in IP Committee is proud to launch a new and updated Law Firm Toolkit that assists legal professionals in law firms to team with their corporate and university clients to increase the diversity in in the innovation ecosphere of the their clients. Cantor Colburn's Tina Dorr, Ph.D., Esq., partner, and Liam Evans, patent agent, members of the IPO Diversity & Inclusion Committee, will be part of an IPO webinar on August 4, 2021 that will walk through the updated toolkit, how to use it, and discuss practical ways for in-house and outside counsel to partner to use the toolkit.
Tina Dorr represents clients in a large range of technology areas, including chemical, material, life science, mechanical, and semiconductor technologies, as well as fiber and fiber composite technologies for consumer product applications, geotextile applications, and aerospace applications. Tina drafts and prosecutes U.S. utility, design, and plant patent applications, as well as manages and directs prosecution of foreign patent portfolios. She provides opinions, performs searches, counsels clients to develop effective worldwide patent protection, and provides technical support and opinions to Cantor Colburn’s Litigation Department in Abbreviated New Drug Application litigation. Prior to joining Cantor Colburn, Tina completed her doctoral thesis on enzyme catalysis, membrane protein structure, and redox chemistry. She is also an active leader in the local and national IP community, currently serving as IPO's Co-Vice-Chair of the Next Generation Leaders Committee.
Liam Evans is a patent agent focusing on the fields of materials science and polymers, specifically on matters related to chemical engineering, nanomaterials, bioimaging, and soil polymers. Before joining Cantor Colburn, Liam’s undergraduate research in the Institute of Materials Science at the University of Connecticut focused on developing a nanodisc platform for drug delivery and bioimaging applications.